Skip to main content
. Author manuscript; available in PMC: 2021 Jul 14.
Published in final edited form as: Annu Rev Biomed Eng. 2021 Mar 29;23:169–201. doi: 10.1146/annurev-bioeng-082120-022836

Table 2.

Selected microbiome biotech startups and ongoing projects

Microbiome Company Overview Project Stages
Plant Pivot Bio Nitrogen fixation Corn supplement Commercialized
AgBiome Pest control Fungicide Commercialized
Boost Biomes Manage disease of high-value crops Reduce crop loss in the field and post-harvest In development
Animal Native Microbials Restore highfunctioning lumen Dairy Commercialized
Other animals In development
AnimalBiome Personalized FMT Pet dogs and cats Commercialized
Human Evelo Biosciences Monoclonal microbials COVID-19 Phase II/III
Psoriasis Phase II
Triple-negative breast cancer Preclinical
Vedanta Biosciences Defined consortia Clostridium difficile infection Phase II
Inflammatory bowel disease Phase I
Cancer immunotherapy Phase I
Food allergy Phase I
Seres Therapeutics Defined consortia C. difficile infection Phase III
Ulcerative colitis Phase II
Metastatic melanoma Phase I
Synlogic Therapeutics Smart living biotherapeutics Phenylketonuria Phase II
Immune-oncology solid tumors Phase I

Abbreviation: COVID-19, coronavirus disease 2019; FMT, fecal microbiota transplantation.